资讯

Medical Dialogues16 分钟
DCC Recommends Licensing, Labelling Restrictions on Anti-TB Drugs to Curb Private Market Misuse
In a move to curb potential misuse of critical tuberculosis medications, the Drugs Consultative Committee (DCC) has ...